MDxHealth SA Sustainability Profile
MDxHealth SA, a leading molecular diagnostics company headquartered in Belgium, is at the forefront of personalised medicine. Founded in 2009, the company has established itself as a key player in the oncology sector, focusing on innovative solutions for cancer diagnosis and management. With a strong presence in Europe and North America, MDxHealth offers unique products such as the ConfirmMDx® test, which aids in the detection of prostate cancer, and the SelectMDx® test, designed for bladder cancer risk assessment. These advanced diagnostic tools leverage proprietary technology to provide clinicians with critical insights, enhancing patient care and treatment outcomes. Recognised for its commitment to improving cancer diagnostics, MDxHealth continues to expand its market position, contributing significantly to the evolving landscape of precision medicine.
DitchCarbon Score
How does MDxHealth SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MDxHealth SA's score of 26 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MDxHealth SA's reported carbon emissions
MDxHealth SA, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MDxHealth SA may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company does not appear to be actively participating in industry-standard climate frameworks such as the Science Based Targets initiative (SBTi) or similar programmes.
How Carbon Intensive is MDxHealth SA's Industry?
How Carbon Intensive is MDxHealth SA's Location?
MDxHealth SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MDxHealth SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
